APA
Pérez de Llano L. A., Cosío B. G., Domingo C., Urrutia I., Bobolea I., Valero A., Entrenas Costa L. M., Quirce S., Barranco P., Marina Malanda N., Andrés L. P. & Alvarez-Gutiérrez F. J. (20201005). Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study. : The journal of allergy and clinical immunology. In practice.
Chicago
Pérez de Llano Luis A, Cosío Borja G, Domingo Christian, Urrutia Isabel, Bobolea Irina, Valero Antonio, Entrenas Costa Luis M, Quirce Santiago, Barranco Pilar, Marina Malanda Nuria, Andrés Luis Prieto and Alvarez-Gutiérrez Francisco J. 20201005. Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study. : The journal of allergy and clinical immunology. In practice.
Harvard
Pérez de Llano L. A., Cosío B. G., Domingo C., Urrutia I., Bobolea I., Valero A., Entrenas Costa L. M., Quirce S., Barranco P., Marina Malanda N., Andrés L. P. and Alvarez-Gutiérrez F. J. (20201005). Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study. : The journal of allergy and clinical immunology. In practice.
MLA
Pérez de Llano Luis A, Cosío Borja G, Domingo Christian, Urrutia Isabel, Bobolea Irina, Valero Antonio, Entrenas Costa Luis M, Quirce Santiago, Barranco Pilar, Marina Malanda Nuria, Andrés Luis Prieto and Alvarez-Gutiérrez Francisco J. Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study. : The journal of allergy and clinical immunology. In practice. 20201005.